{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T05:07:34Z","timestamp":1789103254748,"version":"build-2803163510"},"reference-count":41,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T00:00:00Z","timestamp":1789084800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Prebiotics, probiotics, and synbiotics have been proposed as adjunctive treatments for acute pancreatitis (AP), but their clinical efficacy and safety remain uncertain. We conducted a systematic review and meta-analysis to evaluate their effects on recovery-related, efficacy, and safety-critical outcomes in AP.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>PubMed, Web of Science, Scopus, Embase, and the Cochrane Library were searched through July 2026, supplemented by Google Scholar and reference-list screening. Comparative interventional and observational studies evaluating prebiotics, probiotics, or synbiotics versus placebo, standard care, or nutritional controls were eligible. Risk of bias was assessed using Cochrane RoB 2 for randomized studies and the Newcastle\u2013Ottawa Scale for non-randomized studies. Random-effects meta-analyses were performed using mean differences (MDs) or risk ratios (RRs) with 95% confidence intervals (CIs). Sensitivity and subgroup analyses were conducted to explore study quality and clinical heterogeneity.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      30 studies were included in the systematic review and 25 in the meta-analysis. Microbiota-directed interventions were associated with a shorter hospital stay in the full-analysis set (MD\u202f\u2212\u202f4.68\u202fdays, 95% CI\u202f\u2212\u202f6.22 to \u22123.14), although heterogeneity was substantial (I\n                      <jats:sup>2<\/jats:sup>\n                      \u202f=\u202f98.74%); the association persisted in the sensitivity analysis (MD\u202f\u2212\u202f3.90\u202fdays, 95% CI\u202f\u2212\u202f5.93 to \u22121.87). Mortality was lower in the full analysis (RR 0.67, 95% CI 0.45\u20130.98), but this finding was not robust and lost statistical significance in the sensitivity analysis. Total infection (RR 0.50, 95% CI 0.36\u20130.69) and infectious morbidity (RR 0.58, 95% CI 0.42\u20130.80) were reduced, whereas infected pancreatic necrosis, organ failure\/multiple organ failure, need for operation, and systemic inflammatory response syndrome were not significantly improved overall. Adverse-event reporting was inconsistent, and a large multicenter trial provided an important safety signal for live multispecies probiotics in predicted severe AP.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Microbiota-directed interventions may be associated with shorter hospital stay and fewer infection-related complications, but substantial heterogeneity, intervention diversity, and incomplete safety reporting limit clinical interpretation. Evidence for mortality or other severe outcomes is not robust. Current evidence does not support routine use of these interventions in AP, particularly live probiotic preparations in severe or critically ill patients. Future adequately powered, severity-stratified trials using standardized formulations and prospective safety monitoring are needed.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Systematic review registration<\/jats:title>\n                    <jats:p>Registration number: CRD420261387279.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fmed.2026.1873327","type":"journal-article","created":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T04:32:15Z","timestamp":1789101135000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Safety and efficacy of microbiota-directed adjunctive therapy in acute pancreatitis: a systematic review and meta-analysis of prebiotics, probiotics, and synbiotics"],"prefix":"10.3389","volume":"13","author":[{"given":"Ji","family":"Sun","sequence":"first","affiliation":[{"name":"Department of Critical Care Medicine, Inner Mongolia People's Hospital, Affiliated to Baotou Medical College","place":["Hohhot, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Zheng","sequence":"additional","affiliation":[{"name":"Department of Critical Care Medicine, Inner Mongolia People's Hospital, Affiliated to Baotou Medical College","place":["Hohhot, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ye","family":"Shen","sequence":"additional","affiliation":[{"name":"Department of Critical Care Medicine, Inner Mongolia People's Hospital, Affiliated to Baotou Medical College","place":["Hohhot, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,9,11]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"1729","DOI":"10.12669\/pjms.40.8.9744","article-title":"Effect of probiotics combined with Ulinastatin and somatostatin in the treatment of severe acute pancreatitis","volume":"40","author":"Dou","year":"2024","journal-title":"Pak J Med Sci"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"R57","DOI":"10.1186\/cc13809","article-title":"Use of probiotics in the treatment of severe acute pancreatitis: a systematic review and meta-analysis of randomized controlled trials","volume":"18","author":"Gou","year":"2014","journal-title":"Crit Care"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"e36454","DOI":"10.1097\/MD.0000000000036454","article-title":"Effectiveness and safety of probiotics on patients with severe acute pancreatitis: a systematic review and meta-analysis","volume":"102","author":"Gao","year":"2023","journal-title":"Medicine (Baltimore)"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"690","DOI":"10.3389\/fphar.2018.00690","article-title":"Supplemented use of pre-, pro-, and Synbiotics in severe acute pancreatitis: an updated systematic review and Meta-analysis of 13 randomized controlled trials","volume":"9","author":"Tian","year":"2018","journal-title":"Front Pharmacol"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"16","DOI":"10.12688\/f1000research.134868.1","article-title":"Efficacy of pre, pro, and synbiotic on clinical endpoint of acute pancreatitis: a systematic review and meta-analysis","volume":"13","author":"Mariadi","year":"2024","journal-title":"F1000Res"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"3970","DOI":"10.3748\/wjg.v16.i31.3970","article-title":"Use of pre-, pro- and synbiotics in patients with acute pancreatitis: a meta-analysis","volume":"16","author":"Zhang","year":"2010","journal-title":"World J Gastroenterol"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"1788","DOI":"10.11569\/wcjd.v25.i19.1788","article-title":"Gentamicin combined with probiotics for treatment of patients with severe acute pancreatitis: efficacy and impact on inflammatory factors","volume":"25","author":"Wang","year":"2017","journal-title":"World Chin J Dig"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"4018","DOI":"10.26355\/eurrev_201806_15288","article-title":"Therapeutic effect of Bifidobacterium combined with early enteral nutrition in the treatment of severe acute pancreatitis: a pilot study","volume":"22","author":"Jin","year":"2018","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"240","DOI":"10.37290\/ctnr2641-452x.19:240-247","article-title":"Effects of micro-ecological enteral nutrition on systemic inflammatory response, bacterial translocation, and immune function in patients with severe acute pancreatitis","volume":"19","author":"Wang","year":"2021","journal-title":"Curr Top Nutraceutical Res"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"101044","DOI":"10.1016\/j.hermed.2025.101044","article-title":"Combination therapy of Qi Huang Tong mi soft capsule and probiotics enhances clinical outcomes in severe acute pancreatitis","volume":"53","author":"Ma","year":"2025","journal-title":"J Herb Med"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1016\/j.pan.2012.08.004","article-title":"Probiotic treatment with Probioflora in patients with predicted severe acute pancreatitis without organ failure","volume":"12","author":"van Baal","year":"2012","journal-title":"Pancreatology"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"d5928","DOI":"10.1136\/bmj.d5928","article-title":"The Cochrane collaboration's tool for assessing risk of bias in randomised trials","volume":"343","author":"Higgins","year":"2011","journal-title":"BMJ"},{"key":"ref14","first-page":"13","volume-title":"Estimating the mean and variance from the median, range, and the size of a sample","author":"Hozo","year":""},{"key":"ref15","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1186\/1471-2288-14-135","article-title":"Estimating the sample mean and standard deviation from the sample size, median, range and\/or interquartile range","volume":"14","author":"Wan","year":"2014","journal-title":"BMC Med Res Methodol"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1007\/s10620-022-07618-1","article-title":"Effect of Synbiotics in reducing the systemic inflammatory response and septic complications in moderately severe and severe acute pancreatitis: a prospective parallel-arm double-blind randomized trial","volume":"68","author":"Rohith","year":"2023","journal-title":"Dig Dis Sci"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1371\/journal.pmed.1002028","article-title":"Synbiotic control of inflammation and infection in severe acute pancreatitis: a prospective, randomized, double blind study","volume":"54","author":"Olah","year":"2007","journal-title":"Hepato-Gastroenterology"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"tkag006","DOI":"10.1371\/journal.pone.0083138","article-title":"Saccharomyces boulardii in patients with severe acute pancreatitis: a single Centre, open-label randomized controlled trial","author":"He","year":"2026","journal-title":"Burns Trauma"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"1766361","DOI":"10.3389\/fmed.2026.1766361","article-title":"Influences of probiotics plus enteral nutrition on intestinal flora and inflammatory response in patients with severe acute pancreatitis","volume":"13","author":"Cheng","year":"2026","journal-title":"Front Med (Lausanne)"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"1492108","DOI":"10.3389\/fmed.2024.1492108","article-title":"Observation on the therapeutic effect of probiotics on early oral feeding in the treatment of severe acute pancreatitis","volume":"11","author":"Zhao","year":"2024","journal-title":"Front Med (Lausanne)"},{"key":"ref21","doi-asserted-by":"crossref","DOI":"10.1201\/9781003107347","volume-title":"Doing Meta-Analysis With R: A Hands-On Guide","author":"Harrer","year":""},{"key":"ref22","doi-asserted-by":"publisher","first-page":"224","DOI":"10.3748\/wjg.v27.i2.224","article-title":"Effect of probiotics on length of hospitalization in mild acute pancreatitis: a randomized, double-blind, placebo-controlled trial","volume":"27","author":"Wan","year":"2021","journal-title":"World J Gastroenterol"},{"key":"ref23","volume-title":"Cochrane Handbook for Systematic Reviews of Interventions","author":"Higgins","year":""},{"key":"ref24","doi-asserted-by":"publisher","first-page":"270","DOI":"10.11569\/wcjd.v26.i4.270","article-title":"Effect of probiotics plus antibiotics on inflammatory cytokines and quality of life in patients with non-biliary severe acute pancreatitis","volume":"26","author":"Fang","year":"2018","journal-title":"World Chin J Digestol"},{"key":"ref25","first-page":"1403","article-title":"Effect and safety of probiotics combined early enteral nutrition on severe acute pancreatitis patients","volume":"28","author":"Wu","year":"2017","journal-title":"Biomed Res"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"5875","DOI":"10.11569\/wcjd.v23.i36.5875","article-title":"Efficacy of early application of enteral nutrition combined with probiotics in treatment of severe acute pancreatitis","volume":"23","author":"Liu","year":"2015","journal-title":"World Chin J Digestol"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"5013","DOI":"10.1201\/9781003107347","article-title":"Effects of probiotics in treatment of severe acute pancreatitis","volume":"22","author":"Zhu","year":"2014","journal-title":"World Chin J Dig"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"5609","DOI":"10.11569\/wcjd.v22.i36.5609","article-title":"Effect of early enteral nutrition with Bifico on levels of inflammatory mediators in plasma of patients with severe acute pancreatitis","volume":"22","author":"Li","year":"2014","journal-title":"World Chin J Dig"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1016\/j.jss.2012.12.010","article-title":"Effect of enteral nutrition and ecoimmunonutrition on bacterial translocation and cytokine production in patients with severe acute pancreatitis","volume":"183","author":"Wang","year":"2013","journal-title":"J Surg Res"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"224","DOI":"10.3760\/cma.j.issn.2095-4352.2013.04.011","article-title":"The effects of early enteral nutrition with addition of probiotics on the prognosis of patients suffering from severe acute pancreatitis","volume":"25","author":"Cui","year":"2013","journal-title":"Zhonghua Wei Zhong Bing Ji Jiu Yi Xue"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1097\/MCG.0b013e318201f9e2","article-title":"Role of probiotics on gut permeability and endotoxemia in patients with acute pancreatitis: a double-blind randomized controlled trial","volume":"45","author":"Sharma","year":"2011","journal-title":"J Clin Gastroenterol"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.jclinepi.2017.05.006","article-title":"Probiotics in acute pancreatitis--a randomised, placebo-controlled, double-blind study","volume":"56","author":"Lata","year":"2010","journal-title":"Vnitr Lek"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1186\/2046-4053-1-2","article-title":"Adjuvant therapy for probiotics in patients with severe acute pancreatitis with hepatic lesion: an analysis of 27 cases","volume":"29","author":"Wu","year":"2009","journal-title":"Clin Med"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"1854","DOI":"10.1186\/2046-4053-1-1","article-title":"Early enteral application of probiotics improved the changes of inflammatory mediators and its relationship with the prognosis in the patients with severe acute pancreatitis","volume":"18","author":"Cui","year":"2009","journal-title":"Chin J New Drugs"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1038\/sj.ejcn.1602792","article-title":"Effect of Lactobacillus plantarum enteral feeding on the gut permeability and septic complications in the patients with acute pancreatitis","volume":"62","author":"Qin","year":"2008","journal-title":"Eur J Clin Nutr"},{"key":"ref36","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1016\/s0140-6736(08)60207-x","article-title":"Probiotic prophylaxis in predicted severe acute pancreatitis: a randomised, double-blind, placebo-controlled trial","volume":"371","author":"Besselink","year":"2008","journal-title":"Lancet"},{"key":"ref37","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1016\/j.jclinepi.2017.11.022","article-title":"Adjuvant therapy for probiotics in patients with severe acute pancreatitis: an analysis of 14 cases","volume":"15","author":"Li","year":"2007","journal-title":"World Chin J Dig"},{"key":"ref38","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1046\/j.1365-2168.2002.02189.x","article-title":"Randomized clinical trial of specific lactobacillus and fibre supplement to early enteral nutrition in patients with acute pancreatitis","volume":"89","author":"Olah","year":"2002","journal-title":"Br J Surg"},{"key":"ref39","doi-asserted-by":"publisher","first-page":"5267","DOI":"10.1038\/s41598-025-89739-x","article-title":"Early enteral nutrition with fructooligosaccharides improves prognosis in severe acute pancreatitis","volume":"15","author":"Liu","year":"2025","journal-title":"Sci Rep"},{"key":"ref40","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1080\/00015458.2012.11680811","article-title":"Early low volume oral synbiotic\/prebiotic supplemented enteral stimulation of the gut in patients with severe acute pancreatitis: a prospective feasibility study","volume":"112","author":"Plaudis","year":"2012","journal-title":"Acta Chir Belg"},{"key":"ref41","doi-asserted-by":"publisher","first-page":"2733","DOI":"10.1136\/bmj.n160","article-title":"Comparison of early enteral nutrition in severe acute pancreatitis with prebiotic fiber supplementation versus standard enteral solution: a prospective randomized double-blind study","volume":"13","author":"Karakan","year":"2007","journal-title":"World J Gastroenterol"}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2026.1873327\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T04:32:29Z","timestamp":1789101149000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2026.1873327\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,11]]},"references-count":41,"alternative-id":["10.3389\/fmed.2026.1873327"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2026.1873327","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,11]]},"article-number":"1873327"}}